Literature DB >> 23628741

Genes and environments in schizophrenia: The different pieces of a manifold puzzle.

János M Réthelyi1, Judit Benkovits, István Bitter.   

Abstract

Genetic research targeting schizophrenia has undergone tremendous development during recent years. Supported by recently developed high-throughput genotyping technologies, both rare and common genetic variants have been identified that show consistent association with schizophrenia. These results have been replicated by independent studies and refined in meta-analyses. The genetic variation uncovered consists of common alleles, i.e. single nucleotide polymorphisms (SNPs) conveying small effects (odds ratios below 1.1) on disease risk. The source of rare variants is copy number variations (CNVs), only detectable in a small proportion of patients (3-5% for all known CNVs) with schizophrenia, furthermore extremely rare de novo mutations captured by next generation sequencing, the most recent technological advancement in the field. Despite these findings, the search for the genetic architecture underlying schizophrenia continues since these variants explain only a small proportion of the overall phenotypic variance. Gene-environment interactions provide a compelling model for resolving this paradox and interpreting the risk factors of schizophrenia. Epidemiologically proven risk factors, such as prenatal infection, obstetric complications, urbanicity, cannabis, and trauma have been demonstrated to interact with genetic risk, giving rise to higher prevalence rates or more severe symptomatology in individuals with direct or indirect genetic predisposition for schizophrenia. Further research will have to explain how the different forms of genetic variation interact and how environmental factors modulate their effects. Moreover, the challenging question lying ahead of us is how genetic and environmental factors translate to molecular disease pathways. New approaches, including animal studies and in vitro disease modeling, as well as innovative real-world environment assessment methods, will help to understand the complex etiology of schizophrenia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CNV; Environment; Genetic; Gene–environment interaction; In vitro disease modeling; Next generation sequencing; SNP; Schizophrenia

Mesh:

Year:  2013        PMID: 23628741     DOI: 10.1016/j.neubiorev.2013.04.010

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  18 in total

Review 1.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

2.  Attitudes towards cannabis use and genetic testing for schizophrenia.

Authors:  Jason Schiffman; Ryan E Lawrence; Caroline Demro; Paul S Appelbaum; Lisa B Dixon
Journal:  Early Interv Psychiatry       Date:  2014-06-23       Impact factor: 2.732

3.  Female gender specific association of the Reelin (RELN) gene rs7341475 variant with schizophrenia.

Authors:  Mavi Deniz Sozuguzel; Ali Sazci; Mustafa Yildiz
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

4.  Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia.

Authors:  Paula Rovira; Blanca Gutiérrez; Antonio Sorlózano-Puerto; José Gutiérrez-Fernández; Esther Molina; Margarita Rivera; Rafael Martínez-Leal; Inmaculada Ibanez-Casas; María Victoria Martín-Laguna; Araceli Rosa; Francisco Torres-González; Jorge A Cervilla
Journal:  Genes (Basel)       Date:  2022-06-18       Impact factor: 4.141

Review 5.  Major histocompatibility complex I in brain development and schizophrenia.

Authors:  A Kimberley McAllister
Journal:  Biol Psychiatry       Date:  2013-10-10       Impact factor: 13.382

6.  Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome.

Authors:  Yael Midbari Kufert; Ariela Nachmani; Einat Nativ; Abraham Weizman; Doron Gothelf
Journal:  J Neural Transm (Vienna)       Date:  2016-08-12       Impact factor: 3.575

7.  Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia.

Authors:  Tiebing Liu; Qing-Bin Lu; Lailai Yan; Jing Guo; Fangbo Feng; Jinyun Qiu; Jingyu Wang
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

8.  The Danish High Risk and Resilience Study--VIA 7--a cohort study of 520 7-year-old children born of parents diagnosed with either schizophrenia, bipolar disorder or neither of these two mental disorders.

Authors:  Anne A E Thorup; Jens Richardt Jepsen; Ditte Vestbjerg Ellersgaard; Birgitte Klee Burton; Camilla Jerlang Christiani; Nicoline Hemager; Mette Skjærbæk; Anne Ranning; Katrine Søborg Spang; Ditte Lou Gantriis; Aja Neergaard Greve; Kate Kold Zahle; Ole Mors; Kerstin Jessica Plessen; Merete Nordentoft
Journal:  BMC Psychiatry       Date:  2015-10-02       Impact factor: 3.630

9.  Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients.

Authors:  L F Wockner; E P Noble; B R Lawford; R McD Young; C P Morris; V L J Whitehall; J Voisey
Journal:  Transl Psychiatry       Date:  2014-01-07       Impact factor: 6.222

Review 10.  The impact of environmental factors in severe psychiatric disorders.

Authors:  Andrea Schmitt; Berend Malchow; Alkomiet Hasan; Peter Falkai
Journal:  Front Neurosci       Date:  2014-02-11       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.